erhui1979 / iStockphoto.com
As CEO of the UK BioIndustry Association, Steve Bates works closely with industry and government and, by 2025, he wants the UK to become home to the third biggest global biotech cluster, as he explains to LSIPR.
From working as senior director at Genzyme to advising the UK government, Steve Bates has had a varied career, and he’s certainly no stranger to influencing public policy.
Since 2012, he’s settled into the role of CEO of the UK BioIndustry Association (BIA), a trade body founded more than 20 years ago at the infancy of biotechnology.
Bates has been involved in major BIA campaigns for improved access to finance, the extension of the UK Biomedical Catalyst (BMC), anti-microbial resistance and the opportunity the sector presents to long-term investors.
To continue reading this article and to access our full archive, digital magazines and special reports you will need a subscription.
If you have already subscribed please login.
For multi-user price options, or to check if your company has an existing subscription we can add you into, please email Atif at firstname.lastname@example.org
If you have any technical issues please email tech support.
For access to the complete website and archive choose '12 MONTH SUBSCRIPTION'. For a free, two-week trial select ‘TWO WEEK FREE TRIAL’.
Steve Bates, UK BioIndustry Association, BIA, industry, Brexit, UK biotech sector, LSIPR, BioIndustry, government